AAAAAA

   
Results: 1-17 |
Results: 17
Chronic donepezil treatment is associated with slowed cognitive decline inAlzheimer's disease
Authors: Doody, RS Dunn, JK Clark, CM Farlow, M Foster, NL Liao, T Gonzales, N Lai, E Massman, P
Citation: Rs. Doody et al., Chronic donepezil treatment is associated with slowed cognitive decline inAlzheimer's disease, DEMENT G C, 12(4), 2001, pp. 295-300
Caregivers' attitudes toward their family members' participation in Alzheimer disease research: Implications for recruitment and retention
Authors: Connell, CM Shaw, BA Holmes, SB Foster, NL
Citation: Cm. Connell et al., Caregivers' attitudes toward their family members' participation in Alzheimer disease research: Implications for recruitment and retention, ALZ DIS A D, 15(3), 2001, pp. 137-145
Social and ethical issues in the care of patients with dementia
Authors: Barbas, NR Foster, NL
Citation: Nr. Barbas et Nl. Foster, Social and ethical issues in the care of patients with dementia, J GER PSY N, 14(4), 2001, pp. 167-167
Assessment of muscarinic receptor concentrations in affinity and Alzheimerdisease with [C-11]NMPB and PET
Authors: Zubieta, JK Koeppe, AR Frey, KA Kilbourn, MR Mangner, TJ Foster, NL Kuhl, DE
Citation: Jk. Zubieta et al., Assessment of muscarinic receptor concentrations in affinity and Alzheimerdisease with [C-11]NMPB and PET, SYNAPSE, 39(4), 2001, pp. 275-287
Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation
Authors: Minoshima, S Foster, NL Sima, AAF Frey, KA Albin, RL Kuhl, DE
Citation: S. Minoshima et al., Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation, ANN NEUROL, 50(3), 2001, pp. 358-365
Central acetylcholinesterase inhibition in Alzheimer patients - Reply
Authors: Kuhl, DE Minoshima, S Frey, KA Foster, NL Kilbourn, MR Koeppe, RA
Citation: De. Kuhl et al., Central acetylcholinesterase inhibition in Alzheimer patients - Reply, ANN NEUROL, 49(3), 2001, pp. 416-417
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex
Authors: Lynch, T Sano, M Marder, KS Bell, KL Foster, NL Defendini, RF Sima, AAF Keohane, C Nygaard, TG Fahn, S Mayeux, R Rowland, LP Wilhelmsen, KC
Citation: T. Lynch et al., Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex, NEUROLOGY, 57(10), 2001, pp. S39-S45
Neuropathologic correlates of dysarthria in progressive supranuclear palsy- In reply
Authors: Kluin, KJ Gilman, S Foster, NL D'Amato, CJ Bluemlein, L Little, R Sima, AAF Bruch, LA Johanns, JR
Citation: Kj. Kluin et al., Neuropathologic correlates of dysarthria in progressive supranuclear palsy- In reply, ARCH NEUROL, 58(9), 2001, pp. 1500-1500
Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss
Authors: Bozoki, A Giordani, B Heidebrink, JL Berent, S Foster, NL
Citation: A. Bozoki et al., Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss, ARCH NEUROL, 58(3), 2001, pp. 411-416
Neuropathological correlates of dysarthria in progressive supranuclear palsy
Authors: Kluin, KJ Gilman, S Foster, NL Sima, AAF D'Amato, CJ Bruch, LA Bluemlein, L Little, R Johanns, J
Citation: Kj. Kluin et al., Neuropathological correlates of dysarthria in progressive supranuclear palsy, ARCH NEUROL, 58(2), 2001, pp. 265-269
Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex
Authors: Kuhl, DE Minoshima, S Frey, KA Foster, NL Kilbourn, MR Koeppe, RA
Citation: De. Kuhl et al., Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex, ANN NEUROL, 48(3), 2000, pp. 391-395
Balanced centralized and distributed database design in a clinical research environment
Authors: Foster, NL Gombosi, E Teboe, C Little, RJA
Citation: Nl. Foster et al., Balanced centralized and distributed database design in a clinical research environment, STAT MED, 19(11-12), 2000, pp. 1531-1544
Treatment of agitation in AD - A randomized, placebo-controlled clinical trial
Authors: Teri, L Logsdon, RG Peskind, E Raskind, M Weiner, MF Tractenberg, RE Foster, NL Schneider, LS Sano, M Whitehouse, P Tariot, P Mellow, AM Auchus, AP Grundman, M Thomas, RG Schafer, K Thal, LJ
Citation: L. Teri et al., Treatment of agitation in AD - A randomized, placebo-controlled clinical trial, NEUROLOGY, 55(9), 2000, pp. 1271-1278
PET measures of benzodiazepine receptors in progressive supranuclear palsy
Authors: Foster, NL Minoshima, S Johanns, J Little, R Heumann, ML Kuhl, DE Gilman, S
Citation: Nl. Foster et al., PET measures of benzodiazepine receptors in progressive supranuclear palsy, NEUROLOGY, 54(9), 2000, pp. 1768-1773
Neuropathology of chromosome-17-linked dementia
Authors: Sima, AAF D'Amato, C Foster, NL
Citation: Aaf. Sima et al., Neuropathology of chromosome-17-linked dementia, DEMENT G C, 10, 1999, pp. 61-63
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease
Authors: Kuhl, DE Koeppe, RA Minoshima, S Snyder, SE Ficaro, EP Foster, NL Frey, KA Kilbourn, MR
Citation: De. Kuhl et al., In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease, NEUROLOGY, 52(4), 1999, pp. 691-699
When do strokes cause dementia? Effects of subcortical cerebral infarctionon cortical glucose metabolism and cognitive function
Authors: Foster, NL Hickenbottom, SL
Citation: Nl. Foster et Sl. Hickenbottom, When do strokes cause dementia? Effects of subcortical cerebral infarctionon cortical glucose metabolism and cognitive function, ARCH NEUROL, 56(7), 1999, pp. 778-779
Risultati: 1-17 |